|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 277, Issue 6, 3809-3812, February 8, 2002
From the
Received for publication, November 7, 2001, and in revised form, December 13, 2001
Preincubation of 3T3-L1 adipocytes in
high glucose or glucosamine decreases acute insulin (100 nM)-stimulated glucose transport provided that
insulin (0.6 nM) is included during preincubation. GLUT4
expression is unchanged (Nelson, B. A., Robinson, K. A., and
Buse, M. G. (2000) Diabetes 49, 981-991).
Munc18-c, a Syntaxin 4-binding protein, is a proposed regulator
of the docking/fusion of GLUT4-containing vesicles with the plasma
membrane. We examined the subcellular distribution of Munc18-c in
response to acute (15-min) insulin (100 nM) stimulation
after preincubation in 5 or 25 mM glucose ± 0.6 nM insulin. Immunoblotting detected Munc18-c mainly in the
Triton X-100-soluble plasma membrane (TS-PM) and the Triton
X-100-insoluble low density microsomal (TI-LDM) fraction. Under each
condition except high glucose + insulin preincubation, acute insulin
increased Munc18-c (~50-200%) in TS-PM and decreased Munc18-c
(~60%) in TI-LDM. Munc18-c traffic was time-dependent with a lag time of ~3 min compared with GLUT4. Preincubation with high glucose + 0.6 nM insulin significantly impaired acute
insulin-stimulated Munc18-c trafficking and decreased basal Munc18-c in
the TI-LDM. Preincubation with glucosamine + insulin had similar
effects. Total cellular Munc18-c remained unchanged. In conclusion,
acute insulin stimulation promotes the translocation of
Munc18-c, apparently from a TI-LDM-associated compartment to the TS-PM.
Chronically increased glucose flux or exposure to glucosamine disrupts
this process, which may negatively impact the fusion of
GLUT4-containing vesicles with the plasma membrane.
Insulin lowers plasma glucose in part by accelerating glucose
transport into insulin-responsive tissues, i.e. skeletal
muscle, heart muscle, and adipocytes, which express the
insulin-responsive glucose transporter
GLUT4.1 Under basal
conditions, glucose transporters constitutively cycle between the
plasma membrane (PM) and intracellular compartments, but
GLUT4-containing vesicles (GCVs) are for the most part
segregated intracellularly. Insulin accelerates GCV exocytosis much
more than endocytosis (recycling), resulting in a net increase in
PM-associated GLUT4. Acceleration of glucose transport requires that
the translocated GCVs dock at and fuse with the PM (for a review, see
Ref. 2). The latter process mimics small synaptic vesicle traffic in
neurons (3). SNARE proteins in the vesicle membrane (v-SNARE) bind specifically and with high affinity to SNARE proteins in the target membrane (t-SNARE). Adipocytes express isoforms of both t-SNARE and
v-SNARE proteins, and insulin-stimulated GLUT4 trafficking requires
SNARE complex interaction (4). Specifically, the interaction of VAMP-2
(5) in GCVs with Syntaxin 4 (6-8) and SNAP-23 (9, 10) at the PM is
required for the docking and fusion of GCVs in response to insulin stimulation.
The interaction of VAMP-2 and Syntaxin 4/SNAP-23 is regulated by
several proteins (for a review, see Ref. 11). We focused on a
syntaxin-binding protein, Munc18-c. Munc proteins share homology with
two vesicle-trafficking regulators Sec1 in Saccharomyces cerevisiae and unc-18 in Caenorhabditis elegans.
Munc18-a is expressed only in neuronal tissue (12). Munc18-b and -c are
expressed in adipocytes, but only the latter regulates GLUT4
trafficking (7, 13, 14). Overexpression of Munc18-c inhibited GLUT4 translocation in response to insulin (15). This inhibitory effect was
mitigated by co-expression of Syntaxin 4 (14). In cells that were
co-transfected with tagged Munc18-c and Syntaxin 4, a 30-min insulin
exposure decreased the localization of transfected Munc18-c to the PM
and the association between Munc18-c and Syntaxin 4. Interestingly,
microinjection of Munc18-c peptide fragments, which compete with
endogenous Munc18-c for binding to Syntaxin 4, resulted, upon insulin
stimulation, in GCVs clustered at but not fused with the PM (14). Thus
Munc18-c may play a profusogenic role in GCV trafficking.
Sustained hyperglycemia causes insulin resistance in humans and reduces
the insulin response of glucose transport in experimental animals and
cell culture models (for reviews, see Refs. 16 and 17). We found that
in 3T3-L1 adipocytes preincubation in high glucose (25 mM)
or in low glucose (5 mM) supplemented with GlcN (1-2.5
mM) decreased the subsequent acute insulin response of glucose transport by 40-50% (compared with cells pre-exposed to low
glucose) but only if a relatively low dose of insulin (0.6 nM) was included in all media during preincubation. As
assessed by the PM lawn assay, high glucose did not reduce
insulin-stimulated GLUT4 translocation, while GlcN did. Total GLUT4 and
GLUT1 protein expression was not affected by any of the preincubation
conditions. IRS-1-associated PI 3-kinase activation in response to
acute insulin stimulation was also unaffected (1). However,
pre-exposure to high glucose, but not to glucosamine, diminished acute
insulin-stimulated Akt activation (18). We hypothesized that high
glucose preincubation may have impacted GCV docking and/or fusion (1).
In this paper we examined whether acute insulin stimulation regulates
the subcellular distribution of Munc18-c and whether this process is
altered in insulin-resistant 3T3-L1 adipocytes.
Materials--
A site-specific polyclonal rabbit antibody
against Munc18-c was generously provided by Dr. Jeffrey Pessin
(University of Iowa, Iowa City, IA; Ref. 13), and one specific for
GLUT4 was provided by Dr. Mike Mueckler (Washington University, St.
Louis, MO). A polyclonal antibody against Caveolin-1 was from Santa
Cruz Biotechnology (Santa Cruz, CA), horseradish peroxidase-conjugated
goat anti-rabbit IgG was from Jackson Immunoresearch Laboratories (West
Grove, PA), and enhanced chemiluminescence reagents were from Pierce. Other reagents were purchased from previously identified suppliers (1).
Cell Culture and General Methods--
3T3-L1 fibroblasts were
grown in 100-mm culture dishes and differentiated into adipocytes as
described previously (1). Before experiments, cells were preincubated
for 18 h in Dulbecco's minimal essential medium containing 1%
FBS and sugars at concentrations indicated in the figure legends with
or without 0.6 nM insulin. They were re-equilibrated in
serum and insulin-free media for 2 h and then stimulated
for 15 min with or without 100 nM insulin (1).
Subcellular Fractionation--
Subcellular fractions were
generated by differential centrifugation (13, 18). Pellets of the
prepared PM and LDM fractions were resuspended in HES buffer containing
1% Triton X-100, solubilized for at least 1 h at 4 °C, and
then centrifuged for 75 min at 200,000 × g. The Triton
X-100-soluble fractions (TS-PM and TS-LDM) were collected, and the
Triton X-100-insoluble pellets (TI-PM and TI-LDM) were resuspended in
phosphate-buffered saline containing 1% SDS and heated for 10 min at 95 °C.
SDS-PAGE and Immunoblotting--
Proteins (15 µg) from the
appropriate fractions were separated by SDS-PAGE, transferred to
nitrocellulose or polyvinylidene difluoride membranes, and
immunoblotted at 4 °C overnight with either rabbit anti-Munc18-c
(1:2000), rabbit anti-GLUT4 (1:500), or rabbit anti-Caveolin-1
(1:1000). Immunoreactive bands were detected and quantified, and
protein concentrations were determined as described previously (1).
Statistical Analysis--
Means ± S.E. are shown. Where
error bars are not indicated in the figures, they are too small for
graphical representation. The significance of differences between means
were evaluated by one, two, or three way analysis of variance (ANOVA)
and Tukey's test for unbalanced design using the Statistica software
or by two-tailed, unpaired Student's t test using Microsoft
Excel 98 software. p < 0.05 was considered significant.
The subcellular distribution of GLUT4 was assessed with or without
maximal acute insulin stimulation in cells preincubated in low or high
glucose ± 0.6 nM insulin. The purpose of these studies was
to compare cell fractions obtained by standard differential centrifugation (Fig. 1) with those
obtained with the PM lawn assay (1). As expected, acute insulin
stimulation significantly increased PM-associated GLUT4 irrespective of
the preincubation conditions. However, after acute insulin stimulation
a small (20%) but significant decrease in PM-associated GLUT4 was
observed in cells that had been preincubated with high glucose + 0.6 nM insulin. Similarly, in this group, acute insulin
stimulation failed to decrease GLUT4 associated with the TS-LDM
significantly, while this effect was significant (p < 0.05) in the other three groups. Thus, in contrast to the results
obtained with the PM lawn assay, the cell fractionation studies were
consistent with impaired GLUT4 translocation associated with
insulin-resistant glucose transport in cells pretreated with high
glucose + 0.6 nM insulin. The discrepant results obtained with the two experimental methods may be consistent with impaired docking/fusion of GCVs as the primary defect. In this scenario, a
fraction of GCVs, which did not fuse with the PM, would remain associated with it in the lawn assay, but the relatively weak link
would be disrupted during the more rigorous cell fractionation procedure.
To further assess a putative docking/fusion defect in glucose-induced
insulin resistance, we examined the possibility of altered Munc18-c
trafficking in response to acute insulin stimulation. Previous studies
found Munc18-c primarily localized to the PM (13). As assessed by
immunoblot, Munc18-c levels in our study were highest in the TS-PM,
TI-LDM (Fig. 2), and TI-PM. The latter did not change in response to the experimental manipulations (data not
shown). The Munc18-c signal was too weak to quantify in the TS-LDM and
cytosol (data not shown) and may represent contamination by other
membrane fractions. Total Munc18-c expression did not change in
response to any of the experimental conditions (data not shown).
Acute insulin stimulation increased Munc18-c in the TS-PM ~2-fold in
cells preincubated without 0.6 nM insulin in low or high glucose (p < 0.05). This effect was abolished after
preincubation with 25 mM Glc + 0.6 nM insulin
(Fig. 2, A and C). The interaction between
glucose concentration and the presence of 0.6 nM insulin during preincubation was significant by two way ANOVA
(p < 0.05). In cells preincubated with 0.6 nM insulin in 5 mM glucose, TS-PM-associated Munc18-c was increased in the basal state (p < 0.05),
and the further increase induced by acute insulin stimulation was only borderline significant (p < 0.1). However, in a
subsequent study (Fig. 3A),
acute insulin stimulation significantly (p < 0.05) increased TS-PM-associated Munc18-c under identical conditions. Thus
acute insulin failed to increase Munc18-c in the TS-PM only after
preincubation in high glucose + 0.6 nM insulin, the
condition that induced insulin-resistant glucose transport.
Acute insulin decreased Munc18-c associated with the TI-LDM by ~50-70% under most conditions (Fig. 2, B and D, p < 0.01) when compared with basal. Preincubation with 0.6 nM insulin and 25 mM glucose decreased basal Munc18-c in this fraction by ~50% (Fig. 2D, p < 0.05). Acute insulin caused a further 28% decrease, which was not statistically significant. The interaction between glucose concentration and insulin during preincubation was significant by two way ANOVA (p < 0.05). Caveolin-1 is mainly localized to the TI-LDM and is tyrosine-phosphorylated upon acute insulin stimulation (19). We immunoblotted for Caveolin-1 in TI-LDM to assess the specificity of the acute insulin-induced decrease in Munc18-c in this fraction. The Caveolin-1 concentration in TI-LDM was unaffected by acute insulin stimulation regardless of the preincubation conditions (Fig. 2E) in agreement with previous studies (19, 20). Because preincubation with GlcN + 0.6 nM insulin also caused insulin resistance in our model (1), the subcellular distribution of Munc18-c was examined. Acute insulin stimulation again increased Munc18-c associated with the TS-PM in cells preincubated in 5 mM glucose with or without 0.6 nM insulin (Fig. 3A, p < 0.05), but this effect was not statistically significant in GlcN-pretreated cells. Munc18-c decreased in the TI-LDM ~50-70% after acute insulin stimulation under all conditions (Fig. 3B, p < 0.05). Significant effects of GlcN (p < 0.001) and the presence of 0.6 nM insulin (p < 0.01) during preincubation were detected by two way ANOVA. Basal Munc18-c associated with the TI-LDM was unchanged in all conditions except in cells that had been preincubated in 5 mM glucose + 2.5 mM GlcN + 0.6 nM insulin. In the latter group, basal TI-LDM-associated Munc18-c was decreased by ~50% as compared with cells preincubated in 5 mM glucose + 0.6 nM insulin. Although not significant by Tukey's post hoc analysis, the difference was significant by Student's unpaired t test (p < 0.001). Acute insulin stimulation further decreased Munc18-c in TI-LDM by ~50% in this group. We could not account for the decreased TI-LDM-associated Munc18-c in the basal state in cells pretreated with 0.6 nM insulin in the presence of high glucose (Fig. 2) or glucosamine (Fig. 3) by a corresponding increase in another fraction. All fractions, including high density microsomes, were examined. However, the marked dilution of the cytosol precluded accurate quantitation in this fraction. Acute insulin-stimulated translocation of GCVs to the PM is insulin
dose- and time-dependent (21-24). Fig.
4 compares the early time course of GLUT4
translocation from the TS-LDM to the TS-PM with the changes in Munc18-c
association with the TS-PM and TI-LDM. GLUT4 translocation was
time-dependent and detectable by 2 min after insulin
stimulation. The increase in PM-associated Munc18-c after insulin
stimulation was much smaller (~20%) in these experiments (n = 3) than in previous studies (Fig. 2). However, the
insulin-mediated decrease in TI-LDM-associated Munc18-c was ~40% at
10 min and was time-dependent. There appeared to be an
~3-min lag time between the initiation of GLUT4 translocation and the
mobilization of Munc18-c from the TI-LDM, suggesting that Munc18-c
translocation does not initiate GCV translocation. Assuming that
Munc18-c promotes GCV fusion (14), the first, early phase of the
insulin response may be supported by Munc18-c associated with the TS-PM
in the basal state, while its translocation from the TI-LDM to the
TS-PM may facilitate the full, sustained insulin response.
Alternatively, Munc18-c may promote dissociation of the SNARE complex
after GCV fusion, which after Munc18-c dissociates may render Syntaxin
4 available for docking of the next wave of GCVs.
Because Munc18-c does not contain protein domains necessary for membrane targeting, its PM localization is mediated predominantly via protein-protein interactions (25). Specifically, Munc18-c co-immunoprecipitates with Syntaxin 4 in 3T3-L1 adipocytes (13). In agreement with this study, we found Munc18-c highly associated with the PM. We modified the subcellular fractionation method in Ref. 13 in that each fraction was further separated into Triton X-100-soluble and -insoluble components. This allowed us to observe for the first time the apparent translocation of endogenous Munc18-c from the TI-LDM to the TS-PM in response to acute insulin stimulation. The TI-LDM fraction has been implicated in insulin-regulated traffic of docking/signaling proteins such as IRS-1 and PI 3-kinase (26, 27). The fraction is enriched in cytoskeletal proteins (26) and in caveolar microdomains of the PM, which are rich in caveolin and in detergent-insoluble, glycolipid-enriched lipid rafts (DIG) (19, 20, 27-30). The fraction contains numerous docking, scaffolding, and signaling proteins (28-30) and is also involved in a novel insulin-responsive PI 3-kinase-independent signaling pathway of glucose transport regulation (29, 30). Sec1p, the yeast homologue of Munc18-c, has a higher affinity for assembled SNARE complexes than for the syntaxin homologue itself (31). Thus, docking of GCVs may promote the association of Munc18-c with the PM, possibly facilitating fusion. Alternatively, acute insulin stimulation may cause post-translational modification(s) of Munc18-c. Although there are no data relevant to Munc18-c, Munc18-a function can be regulated by protein kinase C and by cyclin-dependent kinase 5-mediated phosphorylation (32, 33). Protein kinase C activation has been implicated in glucose- and in glucosamine-induced insulin resistance in adipocytes (16). Insulin-regulated trafficking of Munc18-c in this fraction may represent a link between the proximal insulin signaling cascade and GCV docking/fusion. In the model presented, insulin-resistant glucose transport is
associated with a disruption of insulin-regulated Munc18-c trafficking.
Whether or not the dynamics of insulin-stimulated GCV docking/fusion
are impaired in glucose-induced insulin resistance warrants further study.
We gratefully acknowledge the generous gifts of antibodies specific to GLUT4 or to Munc18-c from Drs. Mike Mueckler and Jeffrey Pessin, respectively. We thank Lilly Research Laboratories for gifts of recombinant human insulin.
* This work was supported in part by Research Grant DK-02001 from the NIDDK, National Institutes of Health (to M. G. B.). This paper was presented in part at the 2001 National Meeting of the American Diabetes Association.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Supported by a Medical Scientist Training Grant GM-08716 from the NIGMS, National Institutes of Health.
Published, JBC Papers in Press, December 18, 2001, DOI 10.1074/jbc.C100645200
The abbreviations used are: GLUT, glucose transporter; FBS, fetal bovine serum; GCV, GLUT4-containing vesicle; HES buffer, HEPES, EDTA, sucrose buffer with protease and phosphatase inhibitors; IRS, insulin receptor substrate; LDM, low density microsome; PI, phosphatidylinositol; PM, plasma membrane; TI, Triton X-100-insoluble; TS, Triton X-100-soluble; SNARE, soluble N-ethylmaleimide-sensitive factor attachment protein receptor; v-SNARE, vesicle membrane SNARE; t-SNARE, target membrane SNARE; ANOVA, analysis of variance.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc. This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||